Text Size
1474 studies found for:    Squamous Cell Carcinoma

Modify this search | How to Use Search Results

Show Display Options
Rank Status Study
1 Unknown † The Character of Perfusion Parameters Derived From MDCT Between Adenocarcinoma and Squamous Cell Carcinoma of Lung in the Treatment Course of Radiation Therapy
Conditions: Adenocarcinoma;   Squamous Cell Carcinoma;   Relevant Condition Terms to the Conditions Field
Intervention: Radiation: CT, radiation therapy
2 Recruiting A Phase I Study of LJM716 in Squamous Cell Carcinoma of Head and Neck, or HER2+ Breast Cancer or Gastric Cancer
Conditions: HER2 + Breast Cancer, HER2 + Gastric Cancer, Squamous Cell Carcinoma of Head and Neck, Esophageal Squamous Cell Carcinoma;   HER2 + Breast Cancer;   HER2 + Gastric Cancer;   Squamous Cell Carcinoma of Head and Neck;   Esophageal Squamous Cell Carcinoma
Intervention: Drug: LJM716
3 Recruiting TPF Induction Chemotherapy for Locally Advanced and Resectable Oral Squamous Cell Carcinoma
Conditions: Stage III Oral Cavity Squamous Cell Carcinoma;   Stage IVA Oral Cavity Squamous Cell Carcinoma
Intervention: Drug: TPF induction chemotherapy
4 Terminated Temsirolimus (Torisel®) and Erlotinib (Tarceva®) in Platinum-Refractory/Ineligible, Advanced, Squamous Cell Carcinoma
Condition: Squamous Cell Carcinoma
Interventions: Drug: Tarceva, Torisel;   Drug: 28-day cycles of Tarceva 150 mg by mouth daily and Torisel 15 mg IV weekly
5 Completed Combination Chemotherapy for Locally Advanced Squamous Cell Carcinoma of the Head and Neck
Conditions: Squamous Cell Carcinoma;   Carcinoma of Head/Neck
Interventions: Drug: Taxotere;   Drug: Cisplatin;   Drug: 5-Fluorouracil;   Drug: Leucovorin;   Drug: G-CSF;   Drug: Ciprofloxacin
6 Recruiting Efficacy Comparison Study of Combination Regimens to Treat Advanced Esophageal Squamous Cell Carcinoma
Conditions: First Line Chemotherapy;   Capecitabine Plus Cisplatin Versus Capecitabine Plus Paclitaxel;   Advanced or Recurrent Esophageal Squamous Cell Carcinoma
Intervention: Drug: Capecitabine plus cisplatin(XP) versus capecitabine plus paclitaxel(XT)
7 Active, not recruiting Study of TARCEVA (Erlotinib) as Adjuvant Treatment for Locally Advanced Head and Neck Squamous Cell Carcinoma
Condition: Head and Neck Squamous Cell Carcinoma
Interventions: Drug: Tarceva;   Drug: Tarceva plus sulindac;   Drug: Placebo
8 Completed
Has Results 		Correlation Between Skin Carotenoid Levels and Previous History of Skin Cancer
Conditions: Skin Cancer;   Basal Cell Carcinoma;   Squamous Cell Carcinoma
Intervention:
9 Recruiting A Study of PF-00299804 When Given Through a Feeding Tube in Locally Advanced Head and Neck Squamous Cell Carcinoma
Condition: Head and Neck Squamous Cell Carcinoma
Intervention: Drug: PF-00299804
10 Recruiting Nimotuzumab in Combination With Chemoradiation for Local Advanced Esophageal Squamous Cell Carcinoma
Condition: Local Advanced Esophageal Squamous Cell Carcinoma
Interventions: Drug: Placebo, Radiotherapy and Chemotherapy;   Drug: Nimotuzumab, Radiotherapy and Chemotherapy
11 Recruiting Ph I Vorinostat in the Treatment of Advanced Staged Oropharyngeal Squamous Cell Carcinoma
Conditions: Stage III Squamous Cell Carcinoma of the Oropharynx;   Stage IV Squamous Cell Carcinoma of the Oropharynx
Interventions: Drug: vorinostat;   Drug: cisplatin;   Radiation: radiation therapy;   Procedure: Correlative Studies
12 Completed Prognostic Factor Analysis in Metastatic Esophageal Squamous Cell Carcinoma
Condition: Metastatic Esophageal Squamous Cell Carcinoma
Intervention:
13 Recruiting Phase II Trial of XP Versus XG in Advanced Esophageal Squamous Cell Carcinoma
Condition: Advanced or Recurrent Esophageal Squamous Cell Carcinoma
Interventions: Drug: Capecitabine/Cisplatin(XP);   Drug: Capecitabine/Paditaxel(XG)
14 Completed Erlotinib in Women With Squamous Cell Carcinoma of the Vulvar
Condition: Squamous Cell Carcinoma
Intervention: Drug: Erlotinib
15 Recruiting Comparison of Elective Lymph Node Treatment Versus Clinical Observation in the Absence of Palpable Lymph Nodes for High Risk Skin Squamous Cell Carcinoma (SCC)
Condition: High Risk Cutaneous Squamous Cell Carcinoma
Intervention: Procedure: elective lymph node dissection
16 Completed
Has Results 		Dasatinib in Patients With Head and Neck Squamous Cell Carcinoma
Conditions: Head and Neck Cancer;   Squamous Cell Carcinoma
Intervention: Drug: Dasatinib
17 Terminated Intratumoral PV701 in Treating Patients With Advanced or Recurrent Unresectable Squamous Cell Carcinoma of the Head and Neck
Conditions: Recurrent Salivary Gland Cancer;   Recurrent Squamous Cell Carcinoma of the Hypopharynx;   Recurrent Squamous Cell Carcinoma of the Larynx;   Recurrent Squamous Cell Carcinoma of the Lip and Oral Cavity;   Recurrent Squamous Cell Carcinoma of the Nasopharynx;   Recurrent Squamous Cell Carcinoma of the Oropharynx;   Recurrent Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity;   Salivary Gland Squamous Cell Carcinoma;   Stage III Salivary Gland Cancer;   Stage III Squamous Cell Carcinoma of the Hypopharynx;   Stage III Squamous Cell Carcinoma of the Larynx;   Stage III Squamous Cell Carcinoma of the Lip and Oral Cavity;   Stage III Squamous Cell Carcinoma of the Nasopharynx;   Stage III Squamous Cell Carcinoma of the Oropharynx;   Stage III Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity;   Stage IV Salivary Gland Cancer;   Stage IV Squamous Cell Carcinoma of the Hypopharynx;   Stage IV Squamous Cell Carcinoma of the Larynx;   Stage IV Squamous Cell Carcinoma of the Lip and Oral Cavity;   Stage IV Squamous Cell Carcinoma of the Nasopharynx;   Stage IV Squamous Cell Carcinoma of the Oropharynx;   Stage IV Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity
Intervention: Biological: PV701
18 Completed Study of Docetaxel in Combination With Cisplatin and 5-Fluorouracil in Locally Advanced Squamous Cell Carcinoma of the Head and Neck
Conditions: Advanced Squamous Cell Carcinoma;   Squamous Cell Carcinoma of Head and Neck;   SSCHN
Interventions: Drug: Docetaxel;   Drug: Cisplatin;   Drug: 5-Fluorouracil
19 Recruiting Phase I Study of a Statin + Erlotinib for Advanced Solid Malignancies With Focus on Squamous Cell Carcinomas and NSCLC
Conditions: Squamous Cell Carcinoma;   Non-Small Cell Lung Cancer
Intervention: Drug: Erlotinib + Rosuvastatin
20 Active, not recruiting Proximal Molecular Effects of Concurrent Chemoradiotherapy on Head and Neck Squamous Cell Carcinoma
Condition: Head and Neck Squamous Cell Carcinoma
Intervention: Biological: the arachidonic acid and EGFR signaling pathways and their interaction in HNSCC tumorigenesis,
To Top

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
† Indicates status has not been verified in more than two years